81_FR_34462 81 FR 34358 - National Committee on Vital and Health Statistics: Meeting

81 FR 34358 - National Committee on Vital and Health Statistics: Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 104 (May 31, 2016)

Page Range34358-34359
FR Document2016-12160

Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting.

Federal Register, Volume 81 Issue 104 (Tuesday, May 31, 2016)
[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34358-34359]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12160]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Committee on Vital and Health Statistics: Meeting

AGENCY: National Committee on Vital and Health Statistics (NCVHS), HHS

ACTION: Notice of full committee and subcommittee meetings.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, the Department 
of Health and Human Services (HHS) announces the following advisory 
committee meeting.

DATES: Tuesday, June 14, 2016: 9 a.m.-5:40 p.m.--Full Committee 
Meeting.
    Wednesday, June 15, 2016: 8 a.m.-2:25 p.m.--Full Committee Meeting.
    Thursday, June 16, 2016: 8:30 a.m.-5 p.m.--Privacy Subcommittee 
Meeting on ``Minimum Necessary and the Health Insurance Portability and 
Accountability Act (HIPAA)''.
    Friday, June 17, 2016: 8:15 a.m.-4 p.m.--NCVHS Meeting on Claims-
based Databases for Policy Development and Evaluation.

[[Page 34359]]


ADDRESSES: The public meetings on June 14-16, 2016 will be held at the 
U.S. Department of Health and Human Services, Hubert H. Humphrey 
Building, Room 705-A, 200 Independence Avenue SW., Washington, DC 
20024. The public meeting on June 17, 2016 will be held at the Wilbur 
J. Cohen Building, 330 Independence Avenue SW, Snow Room, #5051, 
Washington, DC 20201. Phone: (202) 690-7100.

FOR FURTHER INFORMATION CONTACT: Substantive program information may be 
obtained from Rebecca Hines, Executive Secretary, NCVHS, National 
Center for Health Statistics, Centers for Disease Control and 
Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone 
(301) 458-4715. Summaries of meetings and a roster of committee members 
are available on the NCVHS home page of the HHS Web site: http://www.ncvhs.hhs.gov/, where further information including an agenda and 
information for remote audio access to the meetings will be posted.
    Should you require reasonable accommodation, please contact the CDC 
Office of Equal Employment Opportunity on (301) 458-4EEO (4336) as soon 
as possible.

SUPPLEMENTARY INFORMATION: 
    Status: Open.
    Purpose: At the June 14-15, 2016 meeting the Committee will hear 
presentations and hold discussions on several health data policy 
topics. The Committee will receive updates from the Department, 
including from the Office of the National Coordinator and the Centers 
for Medicare and Medicaid Services. The Committee will discuss and take 
action on two recommendation letters stemming from the February 16, 
2016 Standards Subcommittee hearing on the proposed Phase IV Operating 
Rules and proposed Attachment Standard. Findings from the June 2015 
Review Committee Hearing on Adopted Transaction Standards, Operating 
Rules, Code Sets and Identifiers also will be discussed. The Committee 
will review the current public health data landscape with briefings 
from the National Center for Health Statistics, U.S. Census Bureau and 
CDC's Center for Surveillance, Epidemiology, and Laboratory Services. 
CMS will provide a briefing on MACRA and the Merit-Based Incentive 
Payment System (MIPS). The Committee will further review its strategic 
plan for 2016 and all Subcommittees will report on work plans and next 
steps. The Subcommittee on Privacy, Confidentiality, and Security will 
brief the full Committee on proceedings from the meeting on De-
identification and the Health Insurance Portability and Accountability 
Act (HIPAA) scheduled for May 24-25, 2016, and discuss preliminary 
findings.
    After the plenary session adjourns, the Work Group on HHS Data 
Access and Use will continue strategic discussions on building a 
framework for guiding principles for data access and use.
    Privacy-specific topics will be addressed during the same week at 
the following meeting: The NCVHS Privacy, Confidentiality and Security 
Subcommittee will hold a one day meeting on June 16, 2016 to review the 
state of implementation of current policies and practices of the Health 
Insurance Portability and Accountability Act (HIPAA) Privacy Minimum 
Necessary provisions. The Subcommittee plans to identify and discuss 
issues and challenges that the industry is facing when addressing this 
requirement for potential recommendations to the HHS Secretary for 
policy and practice guidance addressing compliance with the ``minimum 
necessary'' standard.
    On June 17th the full Committee will hold a meeting to explore the 
current state of the art associated with the collection and use of 
Multipayor claims data bases. These data bases include private data 
bases (sometimes known as Multi-claims Data Bases) and State claims 
data bases referred to as All-Payer Claims Databases (APCDs). The 
purpose of this meeting is to highlight the current state of 
development, challenges, issues, and opportunities faced by these 
initiatives, engage stakeholders on key issues, and identify priority 
areas and opportunities for recommendations to the Secretary of HHS and 
to the industry.


    Dated: May 16, 2016.
James Scanlon,
Deputy Assistant Secretary for Planning and Evaluation, Office of the 
Assistant Secretary for Planning and Evaluation.
[FR Doc. 2016-12160 Filed 5-27-16; 8:45 am]
 BILLING CODE 4151-05-P



                                                34358                          Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices

                                                —Figure 1A for G protein-coupled                           (2) Respondent certified that he is not            accurately reported in the application,
                                                   receptor kinase-2 (GRK2) expression                  currently engaged in or receiving PHS                 report, manuscript, or abstract.
                                                   in NRVCM subjected to cyclical                       support. Respondent agreed that prior to                 (5) If no supervisory plan is provided
                                                   mechanical stretch                                   the submission of an application for                  to ORI, Respondent agreed to provide
                                                —Figure 1B for densitometric analysis                   PHS support for a research project on                 certification to ORI on a quarterly basis
                                                   of GRK2 activity                                     which the Respondent’s participation is               for a period of five (5) years, beginning
                                                —Figure 2A for phosphorylated Rho                       proposed and prior to the Respondent’s                on May 6, 2016, that he has not engaged
                                                   and GRK2 expression in NRVCM                         participation in any capacity on PHS-                 in, applied for, or had his name
                                                   subjected to mechanical stretch                      supported research, Respondent shall                  included on any application, proposal,
                                                —Figure 2B for densitometric analysis                   ensure that a plan for supervision of                 or other request for PHS funds made
                                                   of GRK2 activity                                     Respondent’s duties is submitted to ORI               available through grants, subgrants,
                                                —Figure 3A for phosphorylated Rho                       for approval. The supervision plan must               cooperative agreements, contracts,
                                                   expression in NRVCM after                            be designed to ensure the scientific                  subcontracts, supplements, awards,
                                                   mechanical stretch and treatment                     integrity of Respondent’s research                    fellowships, projects, programs, small
                                                   with protein kinase C (PKC) inhibitor                contribution as outlined below.                       business technology transfer (STTR) and
                                                   chelerythrine (lanes 5 and 6)                        Respondent agreed that he shall not                   small business innovation research
                                                —Figure 3B for densitometric analyses                                                                         (SBIR) programs, conferences, meetings,
                                                                                                        participate in any PHS-supported
                                                   of GRK2 activity after PKC inhibition                                                                      centers, resources, studies, and trials,
                                                                                                        research until such a supervision plan is
                                                   via chelerythrine treatment                                                                                without prior notification to ORI.
                                                                                                        submitted to and approved by ORI.
                                                   D K08 HL081472–05 Progress Report                    Respondent agreed to maintain                            (6) Respondent agreed to exclude
                                                for:                                                    responsibility for compliance with the                himself voluntarily from serving in any
                                                —Figure 1A for phosphorylated Rho                       agreed upon supervision plan.                         advisory capacity to PHS including, but
                                                   and GRK2 expression in NRVCM                            (3) The requirements for Respondent’s              not limited to, service on any PHS
                                                   subjected to mechanical stretch                      supervision plan are as follows:                      advisory committee, board, and/or peer
                                                —Figure 1B for densitometric analyses                                                                         review committee, or as a consultant for
                                                                                                           i. A committee of senior faculty
                                                   of GRK2 activity after PKC inhibition                                                                      a period of five (5) years, beginning on
                                                                                                        members and officials at the institution
                                                   via chelerythrine treatment                                                                                May 6, 2016.
                                                                                                        who are familiar with Respondent’s
                                                   D JBC 2010 for:                                      field of research, but not including
                                                                                                                                                                 (7) As a condition of the Agreement,
                                                —Figure 1B for phosphorylated Rho                                                                             Respondent agreed to the retraction of
                                                                                                        Respondent’s supervisor or
                                                   expression in NTVCM subjected to                                                                           JBC 2010.
                                                                                                        collaborators, will provide oversight and
                                                   stimulation with Ang II                                                                                    FOR FURTHER INFORMATION CONTACT:
                                                                                                        guidance for ten (10) years. The
                                                —Figure 1B for GRK2 expression in                       committee will review primary data for                Director, Office of Research Integrity,
                                                   NRVCM subjected to cyclical                          Respondent’s PHS-supported research                   1101 Wootton Parkway, Suite 750,
                                                   mechanical stretch panel                             on a quarterly basis setting forth the                Rockville, MD 20852, (240) 453–8200.
                                                —Figure 1C for densitometric analysis
                                                                                                        committee meeting dates, Respondent’s                 Kathryn M. Partin,
                                                   of GRK2 activity
                                                —Figure 2A for phosphorylated Rho                       compliance with appropriate research                  Director, Office of Research Integrity.
                                                   expression in NRVCM after                            standards, and confirming the integrity               [FR Doc. 2016–12800 Filed 5–27–16; 8:45 am]
                                                   mechanical stretch and treatment                     of Respondent’s research.                             BILLING CODE 4150–31–P
                                                   with the Ang II type 1 (AT1) receptor                   ii. The committee will conduct an
                                                   antagonist Irbesartan (lanes 5 and 6)                advance review of any PHS grant
                                                —Figure 2B for densitometric analyses                   application (including supplements,                   DEPARTMENT OF HEALTH AND
                                                   of GRK2 activity after PKC inhibition                resubmissions, etc.), manuscripts                     HUMAN SERVICES
                                                   via Irbesartan treatment                             reporting PHS-funded research
                                                —Figure 4C for phosphorylated Rho and                   submitted for publication, and abstracts.             National Committee on Vital and Health
                                                   GRK2 expression in NRVCM                             The review will include a discussion                  Statistics: Meeting
                                                   subjected to mechanical stretch                      with Respondent of the primary data                   AGENCY: National Committee on Vital
                                                —Figure 4D for densitometric analysis                   represented in those documents and                    and Health Statistics (NCVHS), HHS
                                                   of GRK2 activity after RNAi treatment                will include a certification that the data
                                                                                                                                                              ACTION: Notice of full committee and
                                                   Dr. Malhotra has entered into a                      presented in the proposed application/
                                                                                                                                                              subcommittee meetings.
                                                Voluntary Settlement Agreement with                     publication is supported by the research
                                                ORI, in which he voluntarily agreed to                  record.                                               SUMMARY:   Pursuant to the Federal
                                                the administrative actions set forth                       (4) If within five (5) years from the              Advisory Committee Act, the
                                                below:                                                  effective date of the Agreement,                      Department of Health and Human
                                                   (1) Respondent agreed that he had no                 Respondent receives or applies for PHS                Services (HHS) announces the following
                                                intention in applying for or engaging in                support, Respondent agreed that for a                 advisory committee meeting.
                                                U.S. Public Health Service (PHS)-                       period of ten (10) years beginning on the             DATES: Tuesday, June 14, 2016: 9 a.m.–
                                                supported research or otherwise                         date of his employment that any                       5:40 p.m.—Full Committee Meeting.
                                                working with PHS. However, if within                    institution employing him shall submit,                 Wednesday, June 15, 2016: 8 a.m.–
                                                five (5) years of the effective date of the             in conjunction with each application for              2:25 p.m.—Full Committee Meeting.
                                                Agreement (May 6, 2016), Respondent                     PHS funds, or report, manuscript, or                    Thursday, June 16, 2016: 8:30 a.m.–5
                                                receives or applies for PHS support,                    abstract involving PHS-supported                      p.m.—Privacy Subcommittee Meeting
sradovich on DSK3TPTVN1PROD with NOTICES




                                                Respondent agreed to have his research                  research in which Respondent is                       on ‘‘Minimum Necessary and the Health
                                                supervised for a period of ten (10) years               involved, a report and certification to               Insurance Portability and
                                                beginning on the date of his                            ORI at six (6) month intervals that the               Accountability Act (HIPAA)’’.
                                                employment in a position in which he                    data provided by Respondent are based                   Friday, June 17, 2016: 8:15 a.m.–4
                                                receives or applies for PHS support and                 on actual experiments or are otherwise                p.m.—NCVHS Meeting on Claims-based
                                                to notify his employer/institution(s) of                legitimately derived and that the data,               Databases for Policy Development and
                                                the terms of this supervision.                          procedures, and methodology are                       Evaluation.


                                           VerDate Sep<11>2014   20:07 May 27, 2016   Jkt 238001   PO 00000   Frm 00050   Fmt 4703   Sfmt 4703   E:\FR\FM\31MYN1.SGM   31MYN1


                                                                               Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices                                                  34359

                                                ADDRESSES:   The public meetings on                     Accountability Act (HIPAA) scheduled                  Research Hospital Board (Board) as
                                                June 14–16, 2016 will be held at the                    for May 24–25, 2016, and discuss                      authorized by 42 U.S.C. 282(b)(16),
                                                U.S. Department of Health and Human                     preliminary findings.                                 Section 402(b)(16) of the Public Health
                                                Services, Hubert H. Humphrey Building,                    After the plenary session adjourns,                 Service Act, as amended.
                                                Room 705–A, 200 Independence                            the Work Group on HHS Data Access                        It has been determined that the NH
                                                Avenue SW., Washington, DC 20024.                       and Use will continue strategic                       Clinical Center Research Hospital Board
                                                The public meeting on June 17, 2016                     discussions on building a framework for               is in the public interest in connection
                                                will be held at the Wilbur J. Cohen                     guiding principles for data access and                with the performance of duties imposed
                                                Building, 330 Independence Avenue                       use.                                                  on the National Institutes of Health by
                                                SW, Snow Room, #5051, Washington,                         Privacy-specific topics will be                     law, and that these duties can best be
                                                DC 20201. Phone: (202) 690–7100.                        addressed during the same week at the                 performed through the advice and
                                                FOR FURTHER INFORMATION CONTACT:                        following meeting: The NCVHS Privacy,                 counsel of the Board.
                                                Substantive program information may                     Confidentiality and Security                             Inquiries may be directed to Jennifer
                                                be obtained from Rebecca Hines,                         Subcommittee will hold a one day                      Spaeth, Director, Office of Federal
                                                Executive Secretary, NCVHS, National                    meeting on June 16, 2016 to review the                Advisory Committee Policy, Office of
                                                                                                        state of implementation of current                    the Director, National Institutes of
                                                Center for Health Statistics, Centers for
                                                                                                        policies and practices of the Health                  Health, 6701 Democracy Boulevard,
                                                Disease Control and Prevention, 3311
                                                                                                        Insurance Portability and                             Suite 1000, Bethesda, Maryland 20892
                                                Toledo Road, Hyattsville, Maryland
                                                                                                        Accountability Act (HIPAA) Privacy                    (Mail code 4875), Telephone (301) 496–
                                                20782, telephone (301) 458–4715.
                                                                                                        Minimum Necessary provisions. The                     2123, or spaethj@od.nih.gov .
                                                Summaries of meetings and a roster of
                                                committee members are available on the                  Subcommittee plans to identify and                      Dated: May 24, 2016.
                                                NCVHS home page of the HHS Web site:                    discuss issues and challenges that the                Jennifer S. Spaeth,
                                                http://www.ncvhs.hhs.gov/, where                        industry is facing when addressing this               Director, Office of Federal Advisory
                                                further information including an agenda                 requirement for potential                             Committee Policy.
                                                and information for remote audio access                 recommendations to the HHS Secretary                  [FR Doc. 2016–12643 Filed 5–27–16; 8:45 am]
                                                to the meetings will be posted.                         for policy and practice guidance                      BILLING CODE 4140–01–P
                                                   Should you require reasonable                        addressing compliance with the
                                                accommodation, please contact the CDC                   ‘‘minimum necessary’’ standard.
                                                Office of Equal Employment                                On June 17th the full Committee will                DEPARTMENT OF HEALTH AND
                                                Opportunity on (301) 458–4EEO (4336)                    hold a meeting to explore the current                 HUMAN SERVICES
                                                as soon as possible.                                    state of the art associated with the
                                                                                                        collection and use of Multipayor claims               National Institutes of Health
                                                SUPPLEMENTARY INFORMATION:
                                                   Status: Open.                                        data bases. These data bases include
                                                                                                        private data bases (sometimes known as                National Institute of Allergy and
                                                   Purpose: At the June 14–15, 2016                                                                           Infectious Diseases; Notice of Closed
                                                meeting the Committee will hear                         Multi-claims Data Bases) and State
                                                                                                        claims data bases referred to as All-                 Meetings
                                                presentations and hold discussions on
                                                several health data policy topics. The                  Payer Claims Databases (APCDs). The                     Pursuant to section 10(d) of the
                                                Committee will receive updates from                     purpose of this meeting is to highlight               Federal Advisory Committee Act, as
                                                the Department, including from the                      the current state of development,                     amended (5 U.S.C. App.), notice is
                                                Office of the National Coordinator and                  challenges, issues, and opportunities                 hereby given of the following meetings.
                                                the Centers for Medicare and Medicaid                   faced by these initiatives, engage                      The meetings will be closed to the
                                                Services. The Committee will discuss                    stakeholders on key issues, and identify              public in accordance with the
                                                and take action on two recommendation                   priority areas and opportunities for                  provisions set forth in sections
                                                letters stemming from the February 16,                  recommendations to the Secretary of                   552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
                                                2016 Standards Subcommittee hearing                     HHS and to the industry.                              as amended. The grant applications and
                                                on the proposed Phase IV Operating                                                                            the discussions could disclose
                                                Rules and proposed Attachment                             Dated: May 16, 2016.                                confidential trade secrets or commercial
                                                Standard. Findings from the June 2015                   James Scanlon,                                        property such as patentable material,
                                                Review Committee Hearing on Adopted                     Deputy Assistant Secretary for Planning and           and personal information concerning
                                                Transaction Standards, Operating Rules,                 Evaluation, Office of the Assistant Secretary         individuals associated with the grant
                                                Code Sets and Identifiers also will be                  for Planning and Evaluation.                          applications, the disclosure of which
                                                discussed. The Committee will review                    [FR Doc. 2016–12160 Filed 5–27–16; 8:45 am]           would constitute a clearly unwarranted
                                                the current public health data landscape                BILLING CODE 4151–05–P
                                                                                                                                                              invasion of personal privacy.
                                                with briefings from the National Center                                                                          Name of Committee: National Institute of
                                                for Health Statistics, U.S. Census Bureau                                                                     Allergy and Infectious Diseases Special
                                                and CDC’s Center for Surveillance,                      DEPARTMENT OF HEALTH AND                              Emphasis Panel; NIAID Peer Review Meeting.
                                                                                                        HUMAN SERVICES                                           Date: June 21–22, 2016.
                                                Epidemiology, and Laboratory Services.                                                                           Time: 8:00 a.m. to 5:00 p.m.
                                                CMS will provide a briefing on MACRA                                                                             Agenda: To review and evaluate contract
                                                and the Merit-Based Incentive Payment                   National Institutes of Health
                                                                                                                                                              proposals.
                                                System (MIPS). The Committee will                                                                                Place: Hilton Washington/Rockville,
                                                                                                        Notice of Establishment of the NIH
                                                further review its strategic plan for 2016                                                                    Jefferson Room, 1750 Rockville Pike,
sradovich on DSK3TPTVN1PROD with NOTICES




                                                                                                        Clinical Center Research Hospital                     Rockville, MD 20852.
                                                and all Subcommittees will report on
                                                                                                        Board                                                    Contact Person: Nancy Vazquez-
                                                work plans and next steps. The
                                                Subcommittee on Privacy,                                  Pursuant to the Federal Advisory                    Maldonado, Ph.D., Scientific Review Officer,
                                                                                                                                                              Scientific Review Program, Division of
                                                Confidentiality, and Security will brief                Committee Act, as amended (5 U.S.C.                   Extramural Activities, Room 3F52B National
                                                the full Committee on proceedings from                  App.), the Director, National Institutes              Institutes of Health/NIAID, 5601 Fishers
                                                the meeting on De-identification and the                of Health (NIH) announces the                         Lane, MSC 9834, Bethesda, MD 20892–9834,
                                                Health Insurance Portability and                        establishment of the NIH Clinical Center              (240) 669–5044, nvazquez@niaid.nih.gov.



                                           VerDate Sep<11>2014   20:07 May 27, 2016   Jkt 238001   PO 00000   Frm 00051   Fmt 4703   Sfmt 4703   E:\FR\FM\31MYN1.SGM   31MYN1



Document Created: 2016-05-28 03:57:58
Document Modified: 2016-05-28 03:57:58
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of full committee and subcommittee meetings.
DatesTuesday, June 14, 2016: 9 a.m.-5:40 p.m.--Full Committee Meeting.
ContactSubstantive program information may be obtained from Rebecca Hines, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone (301) 458-4715. Summaries of meetings and a roster of committee members are available on the NCVHS home page of the HHS Web site: http:// www.ncvhs.hhs.gov/, where further information including an agenda and information for remote audio access to the meetings will be posted.
FR Citation81 FR 34358 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR